Concepedia

Aaron P. Rapoport

AP

101

Publications

10.8K

Citations

43

H-Index

1985

Active since

Affiliations

University of Maryland, Baltimore(Current)

U-M Rogel Cancer Center

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Moffitt Cancer Center

Stanford University

Aaron P. Rapoport is an author at University of Maryland, Baltimore specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1985–2024

101

Publications

101

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.4K citations · Full text

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus et al. · Blood · 2013 · 1.1K citations

NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl et al. · Nature Medicine · 2015 · 832 citations · Full text

, , +9

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Michael D. Jain, Lei Feng et al. · Journal of Clinical Oncology · 2020 · 752 citations · Full text

Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells

Brian Cameron, Andrew B. Gerry, Joseph Dukes et al. · Science Translational Medicine · 2013 · 660 citations · Full text

Rows per page

1–5 of 101